Prevalence of Parkinson’s disease in Ukraine
Objective: To compare the prevalence of Parkinson's disease (PD) in Ukraine in 2010 and 2014; to compare the prevalence of PD in Ukraine with other…Genetic risk of Parkinson’s disease in the general population
Objective: We investigated whether a genetic risk score for Parkinson's disease (PD) is associated with the risk of incident PD, and whether the risk score…Health related quality of life in patient with Parkinson’s disease using deep brain stimulators (DBS)- A cross sectional study
Objective: This study aimed to investigate the Health Related Quality of Life before and after the placement of Deep brain stimulators in patients with Parkinson's…Promoting optimal physiotherapy practice worldwide: Role of the Association of Physiotherapists in Parkinson’s disease Europe (APPDE)
Objective: To illustrate how the APPDE promotes optimal physiotherapy expertise in Europe and the world in the care of people with Parkinson's. Background: The APPDE…Objective decrement in Parkinson’s disease – A new parameter for the BRAIN tap test
Objective: To evaluate a new parameter – Bradykinesia Index (BI) as an new objective measure within the BRAIN (BRadykinesia Akinesia INcoordination) tap test. Background: The…Expanding the spectrum of ATP1A3 related disorders: Continuum from alternating hemiplegia of childhood to rapid-onset dystonia parkinsonism?
Objective: To report clinical and molecular features of a family showing intrafamilial phenotypic diversity where a novel ATP1A3 mutation was found. Background: Originally there have…Exome sequencing in the Czech patients with early-onset Parkinson’s disease
Objective: To evaluate prevalence of disease causing mutations and other rare variants in patients with the Early-Onset Parkinson's disease (EOPD). Background: Currently, there are four…Two cases of parkinsonism with atypical genetics
Objective: To report and discuss two unrelated patients carrying heterozygous mutations in both Parkin (PARK2) and Glucocerebrosidase (GBA) gene, with atypical Parkinsonian features. Background: Parkin…Mitochondrial dysfunction in skin fibroblasts from single heterozygous ATP13A2 (PARK9) mutation carriers
Objective: To investigate the pathogenic effect of single heterozygous mutations in ATP13A2, we determined the function and morphological changes of mitochondria in skin fibroblasts derived…Gait impairment is more than a motor symptom in Parkinson’s disease
Objective: To examine the relationship of gait impairment of Parkinson's disease (PD) patients with different clinical factors including motor function, non-motor function and cognitive function.…
- « Previous Page
- 1
- …
- 327
- 328
- 329
- 330
- 331
- …
- 405
- Next Page »